A detailed history of Walleye Trading LLC transactions in Cassava Sciences Inc stock. As of the latest transaction made, Walleye Trading LLC holds 114,200 shares of SAVA stock, worth $314,050. This represents 0.01% of its overall portfolio holdings.

Number of Shares
114,200
Previous 3,985 2765.75%
Holding current value
$314,050
Previous $49,000 6757.14%
% of portfolio
0.01%
Previous 0.0%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$12.35 - $26.11 $49,214 - $104,048
3,985 New
3,985 $49,000
Q2 2023

Aug 14, 2023

BUY
$21.59 - $27.88 $583,124 - $753,010
27,009 New
27,009 $662,000
Q1 2021

May 17, 2021

BUY
$7.09 - $87.95 $2,467 - $30,606
348 New
348 $16,000

Others Institutions Holding SAVA

About CASSAVA SCIENCES INC


  • Ticker SAVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 40,097,900
  • Market Cap $110M
  • Description
  • Cassava Sciences, Inc., a clinical stage biotechnology company, develops drugs for neurodegenerative diseases. Its lead therapeutic product candidate is simufilam, a small molecule drug, which is completed Phase 2b clinical trial; and investigational diagnostic product candidate is SavaDx, a blood-based biomarker/diagnostic to detect Alzheimer's...
More about SAVA
Track This Portfolio

Track Walleye Trading LLC Portfolio

Follow Walleye Trading LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Walleye Trading LLC, based on Form 13F filings with the SEC.

News

Stay updated on Walleye Trading LLC with notifications on news.